146 related articles for article (PubMed ID: 10969768)
1. Inactivation of retinoblastoma protein in uveal melanoma by phosphorylation of sites in the COOH-terminal region.
Brantley MA; Harbour JW
Cancer Res; 2000 Aug; 60(16):4320-3. PubMed ID: 10969768
[TBL] [Abstract][Full Text] [Related]
2. Deregulation of the Rb and p53 pathways in uveal melanoma.
Brantley MA; Harbour JW
Am J Pathol; 2000 Dec; 157(6):1795-801. PubMed ID: 11106551
[TBL] [Abstract][Full Text] [Related]
3. Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma.
Coupland SE; Bechrakis N; Schüler A; Anagnostopoulos I; Hummel M; Bornfeld N; Stein H
Br J Ophthalmol; 1998 Aug; 82(8):961-70. PubMed ID: 9828785
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of Rb and p53 in uveal melanomas following plaque radiotherapy.
Brantley MA; Worley L; Harbour JW
Am J Ophthalmol; 2002 Feb; 133(2):242-8. PubMed ID: 11812429
[TBL] [Abstract][Full Text] [Related]
5. Dual inactivation of RB and p53 pathways in RAS-induced melanomas.
Bardeesy N; Bastian BC; Hezel A; Pinkel D; DePinho RA; Chin L
Mol Cell Biol; 2001 Mar; 21(6):2144-53. PubMed ID: 11238948
[TBL] [Abstract][Full Text] [Related]
6. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
Bartkova J; Lukas J; Guldberg P; Alsner J; Kirkin AF; Zeuthen J; Bartek J
Cancer Res; 1996 Dec; 56(23):5475-83. PubMed ID: 8968104
[TBL] [Abstract][Full Text] [Related]
7. Status of RASSF1A in uveal melanocytes and melanoma cells.
Calipel A; Abonnet V; Nicole O; Mascarelli F; Coupland SE; Damato B; Mouriaux F
Mol Cancer Res; 2011 Sep; 9(9):1187-98. PubMed ID: 21788308
[TBL] [Abstract][Full Text] [Related]
8. Promoter hypermethylation: a common cause of reduced p16(INK4a) expression in uveal melanoma.
van der Velden PA; Metzelaar-Blok JA; Bergman W; Monique H; Hurks H; Frants RR; Gruis NA; Jager MJ
Cancer Res; 2001 Jul; 61(13):5303-6. PubMed ID: 11431374
[TBL] [Abstract][Full Text] [Related]
9. Apoptotic and mitogenic stimuli inactivate Rb by differential utilization of p38 and cyclin-dependent kinases.
Nath N; Wang S; Betts V; Knudsen E; Chellappan S
Oncogene; 2003 Sep; 22(38):5986-94. PubMed ID: 12955077
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
Edmunds SC; Kelsell DP; Hungerford JL; Cree IA
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501
[TBL] [Abstract][Full Text] [Related]
11. Expression of p16 in sporadic primary uveal melanoma.
Lamperska K; Mackiewicz K; Kaczmarek A; Kwiatkowska E; Starzycka M; Romanowska B; Heizman J; Stachura J; Mackiewicz A
Acta Biochim Pol; 2002; 49(2):377-85. PubMed ID: 12362979
[TBL] [Abstract][Full Text] [Related]
12. Abnormal cell cycle regulation in primary human uveal melanoma cultures.
Pardo M; Piñeiro A; de la Fuente M; García A; Prabhakar S; Zitzmann N; Dwek RA; Sánchez-Salorio M; Domínguez F; Capeans C
J Cell Biochem; 2004 Nov; 93(4):708-20. PubMed ID: 15660415
[TBL] [Abstract][Full Text] [Related]
13. Controversial relationship between the expression of the RB pathway components and RB protein phosphorylation in human breast cancer.
Montanaro L; Vici M; Donati G; Ceccarelli C; Santini D; Treré D; Derenzini M
Histol Histopathol; 2007 Jul; 22(7):769-75. PubMed ID: 17455150
[TBL] [Abstract][Full Text] [Related]
14. Lack of BRAF mutations in uveal melanoma.
Rimoldi D; Salvi S; Liénard D; Lejeune FJ; Speiser D; Zografos L; Cerottini JC
Cancer Res; 2003 Sep; 63(18):5712-5. PubMed ID: 14522889
[TBL] [Abstract][Full Text] [Related]
15. Abrogation of the p16-retinoblastoma-cyclin D1 pathway in head and neck squamous cell carcinomas.
Park HW; Song SY; Lee TJ; Jeong D; Lee TY
Oncol Rep; 2007 Jul; 18(1):267-72. PubMed ID: 17549378
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-124a is epigenetically regulated and acts as a tumor suppressor by controlling multiple targets in uveal melanoma.
Chen X; He D; Dong XD; Dong F; Wang J; Wang L; Tang J; Hu DN; Yan D; Tu L
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2248-56. PubMed ID: 23404119
[TBL] [Abstract][Full Text] [Related]
17. Distinct and nonoverlapping roles for pRB and cyclin D:cyclin-dependent kinases 4/6 activity in melanocyte survival.
Yu BD; Becker-Hapak M; Snyder EL; Vooijs M; Denicourt C; Dowdy SF
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14881-6. PubMed ID: 14630948
[TBL] [Abstract][Full Text] [Related]
18. p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease.
Omura-Minamisawa M; Diccianni MB; Chang RC; Batova A; Bridgeman LJ; Schiff J; Cohn SL; London WB; Yu AL
Clin Cancer Res; 2001 Nov; 7(11):3481-90. PubMed ID: 11705866
[TBL] [Abstract][Full Text] [Related]
19. Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma.
Chen X; Wang J; Shen H; Lu J; Li C; Hu DN; Dong XD; Yan D; Tu L
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1193-9. PubMed ID: 21051724
[TBL] [Abstract][Full Text] [Related]
20. Status of the NF1 tumor suppressor locus in uveal melanoma.
Foster WJ; Fuller CE; Perry A; Harbour JW
Arch Ophthalmol; 2003 Sep; 121(9):1311-5. PubMed ID: 12963615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]